Effectiveness of chemotherapy after anti‐PD‐1 blockade failure for relapsed and refractory Hodgkin lymphoma

Programmed death‐1 (PD1) blockade is an efficient and safe therapeutic option in patients with relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL). However, a substantial proportion of patients’ progresses or loses the response to anti‐PD1 treatment. We retrospectively investigated the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Casadei, Beatrice, Argnani, Lisa, Morigi, Alice, Lolli, Ginevra, Broccoli, Alessandro, Pellegrini, Cinzia, Nanni, Laura, Stefoni, Vittorio, Coppola, Paolo E., Carella, Matteo, Cavo, Michele, Zinzani, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643640/
https://www.ncbi.nlm.nih.gov/pubmed/32881376
http://dx.doi.org/10.1002/cam4.3262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643640/
https://www.ncbi.nlm.nih.gov/pubmed/32881376
http://dx.doi.org/10.1002/cam4.3262

Ejemplares similares